Treatment with a specified drug

Psoriasis - Treatment with a specified drug Factor

Last reviewed for CCPS 10 June 2012.

Investigative Documents

Medical Report - Drug Treatment as a cause of Psoriasis [MR9152]

Preliminary questions [25209]

25210

there is some evidence that treatment with a drug from the specified list for psoriasis may be a factor in the development or worsening of the condition under consideration.

25211 the veteran has been treated with a drug from the specified list for psoriasis at some time.

25212

the veteran was treated with a drug from the specified list for psoriasis for an illness or injury which is identifiable.

15035the veteran has established the causal connection between the treatment with a drug from the specified list for psoriasis and VEA service for psoriasis.

32371

the veteran was undergoing treatment for the identified illness or injury with a drug from the specified list for psoriasis at the time of the clinical onset of psoriasis.

15036the veteran has established the causal connection between the treatment with a drug from the specified list for psoriasis and VEA service for the clinical onset of psoriasis.

15038the veteran has established the causal connection between the treatment with a drug from the specified list for psoriasis and operational service for the clinical onset of psoriasis.

or

15039the veteran has established the causal connection between the treatment with a drug from the specified list for psoriasis and eligible service for the clinical onset of psoriasis.

or

7334

the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.

7335

the condition under consideration permanently worsened.

25213

the veteran was undergoing treatment for the identified illness or injury with a drug from the specified list for psoriasis at the time of the clinical worsening of psoriasis.

15037the veteran has established the causal connection between the treatment with a drug from the specified list for psoriasis and VEA service for the clinical worsening of psoriasis.

15040the veteran has established the causal connection between the treatment with a drug from the specified list for psoriasis and operational service for the clinical worsening of psoriasis.

or

15041the veteran has established the causal connection between the treatment with a drug from the specified list for psoriasis and eligible service for the clinical worsening of psoriasis.

Clinical onset and operational service [15038]

25217the identified illness or injury, for which treatment with a drug from the specified list for psoriasis was given, is causally related to operational service.

Clinical onset and eligible service [15039]

25219the identified illness or injury, for which treatment with a drug from the specified list for psoriasis was given, is causally related to eligible service.

Clinical worsening and operational service [15040]

25217the identified illness or injury, for which treatment with a drug from the specified list for psoriasis was given, is causally related to operational service.

25218

the clinical onset of psoriasis occurred prior to that part of operational service to which the identified illness or injury, for which treatment with a drug from the specified list for psoriasis was given, is causally related.

Clinical worsening and eligible service [15041]

25219the identified illness or injury, for which treatment with a drug from the specified list for psoriasis was given, is causally related to eligible service.

25220

the clinical onset of psoriasis occurred prior to that part of eligible service to which the identified illness or injury, for which treatment with a drug from the specified list for psoriasis was given, is causally related.

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/psoriasis-m009-l400l401l402l40/rulebase-psoriasis/treatment-specified-drug